- Investing Ideas
- Global Pharmaceuticals & Biotech Healthy potentially undervalued
Global Pharmaceuticals & Biotech Healthy potentially undervalued
Results
173
Companies which are potentially undervalued and in an acceptable financial position.
173 companies
High Tide
Market Cap: CA$283.8m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.33
7D
1.8%
1Y
-21.6%
Trulieve Cannabis
Market Cap: US$1.8b
Operates as a cannabis retailer in the United States.
TRLV
US$9.69
7D
4.2%
1Y
35.3%
Hypera
Market Cap: R$14.6b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$20.72
7D
-3.9%
1Y
-10.9%
CorMedix
Market Cap: US$636.4m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.17
7D
15.1%
1Y
-39.6%
Innovent Biologics
Market Cap: HK$171.0b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$98.25
7D
2.8%
1Y
3.8%
UCB
Market Cap: €41.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€217.30
7D
-3.9%
1Y
12.9%
Elanco Animal Health
Market Cap: US$11.8b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.64
7D
4.0%
1Y
34.9%
Supernus Pharmaceuticals
Market Cap: US$2.8b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$49.03
7D
4.6%
1Y
16.7%
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.10
7D
-0.9%
1Y
-2.6%
Yunnan Baiyao GroupLtd
Market Cap: CN¥88.8b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥49.75
7D
-1.6%
1Y
-12.6%
Hugel
Market Cap: ₩2.7t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩247,000.00
7D
-8.0%
1Y
-19.8%
Prestige Consumer Healthcare
Market Cap: US$2.4b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$50.57
7D
-5.7%
1Y
-22.7%
Virbac
Market Cap: €2.8b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.
VIRP
€330.00
7D
-2.9%
1Y
-2.1%
Diaceutics
Market Cap: UK£120.5m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.42
7D
-4.7%
1Y
3.3%
Bavarian Nordic
Market Cap: DKK 14.4b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 192.80
7D
6.7%
1Y
-18.8%
Dong-E-E-Jiao
Market Cap: CN¥33.0b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥51.74
7D
-2.3%
1Y
1.8%
Decibel Cannabis
Market Cap: CA$66.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
4.5%
1Y
-14.8%
Fennec Pharmaceuticals
Market Cap: US$414.8m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$11.87
7D
-7.1%
1Y
50.1%
Cresco Labs
Market Cap: CA$493.2m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.03
7D
-4.6%
1Y
-27.0%
Journey Medical
Market Cap: US$182.3m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.66
7D
5.4%
1Y
-5.8%
Amoy Diagnostics
Market Cap: CN¥7.1b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥18.35
7D
-1.8%
1Y
-24.4%
Dong-A ST
Market Cap: ₩354.2b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩36,750.00
7D
-5.8%
1Y
-14.8%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.24
7D
0.8%
1Y
-8.1%
Perrigo
Market Cap: US$1.8b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$12.97
7D
0.9%
1Y
-45.0%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€40.05
7D
0.8%
1Y
18.5%
United Laboratories International Holdings
Market Cap: HK$17.1b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$8.69
7D
-3.8%
1Y
-48.9%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩118,300.00
7D
-5.2%
1Y
-10.4%
China Resources Pharmaceutical Group
Market Cap: HK$30.5b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.86
7D
-0.7%
1Y
-6.5%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€59.70
7D
3.3%
1Y
4.1%
Tecan Group
Market Cap: CHF 2.3b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 189.10
7D
4.4%
1Y
10.7%
Viatris
Market Cap: US$18.6b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$16.17
7D
-0.7%
1Y
51.4%
Vanda Pharmaceuticals
Market Cap: US$318.0m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$5.44
7D
10.3%
1Y
20.1%
Cellectis
Market Cap: €192.7m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€2.65
7D
5.7%
1Y
0.2%
ACADIA Pharmaceuticals
Market Cap: US$5.0b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$30.18
7D
2.6%
1Y
20.9%
Protara Therapeutics
Market Cap: US$235.2m
A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.
TARA
US$3.98
7D
1.8%
1Y
30.5%
Curaleaf Holdings
Market Cap: CA$3.4b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$12.80
7D
-7.2%
1Y
21.9%